Debra L. Kearney, MD
Medical Director of Autopsy Pathology
Texas Children's Hospital
Pediatric Cardiac & Surgical Pathology, Texas Children's Hospital
Associate Professor, Pathology & Immunology, Baylor College of Medicine
Languages: English
Get to know Debra L. Kearney, MD
Personal Statement
Dr. Kearney's main clinical and research interests are centered around pediatric cardiovascular disease, particularly congenital heart malformations, cardiomyopathies, myocarditis and transplant pathology. For many years she has been actively involved in integrating cardiac pathology in the training programs for pediatric cardiology, congenital heart surgery, and other clinical services, emphasizing interactive, hands-on learning. She is involved in collaborative studies with Dr. Charles Fraser and Dr. Grande-Allen (Rice University) in efforts to characterize the cellular and matrix phenotype of pediatric heart valves with the goal of developing a tissue engineered pediatric heart valve. Other collaborative efforts include pathology contributions to the development of an interactive teaching module for echocardiographic evaluation of congenitally malformed and cardiomyopathic hearts. She is also collaborating with members of the Society for Cardiovascular Pathology in the development of a web based interactive teaching module on evaluating endomyocardial biopsies from patients with heart transplants.
Education
,
Organizations
,
,
,
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Purevjav E, Arimura T, Augustin S, Huby AC, Takagi K, Nunoda S, Kearney DL, Taylor MD, Terasaki F, Bos JM, Ommen SR, Shibata H, Takahashi M, Itoh-Satoh M, McKenna WJ, Murphy RT, Labeit S, Yamanaka Y, Machida N, Park JE, Alexander PM, Weintraub RG, Kitaura Y, Ackerman MJ, Kimura A, Towbin JA. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Human Molecular Genetics 2012 May 1;21(9):2039-53.
View All Publications